Characteristic values for steady-state isometric stress and three-parameter Hill fits to the Ca2+-activated stress–pCa relationships
| . | WT . | cMyBP-C KO . | ||
|---|---|---|---|---|
| AP | MLCK | AP | MLCK | |
| Fmin (kN m−2) | 1.15 ± 0.10 | 1.37 ± 0.13 | 1.46 ± 0.12 | 1.55 ± 0.12 |
| Fabs (kN m−2) | 13.55 ± 0.55a | 17.76 ± 0.85b | 12.21 ± 0.51 | 12.49 ± 0.67 |
| Fdev (kN m−2) | 12.55 ± 0.53a | 16.56 ± 0.85b | 10.99 ± 0.47 | 11.15 ± 0.62 |
| pCa50 | 5.80 ± 0.02a | 5.95 ± 0.03b | 5.86 ± 0.02a | 6.15 ± 0.03 |
| nH | 6.32 ± 0.42 | 6.34 ± 0.68b | 4.50 ± 0.38 | 4.48 ± 0.34 |
| Fmax (kN m−2) | 13.06 ± 0.60a | 16.50 ± 0.81b | 11.14 ± 0.51 | 11.40 ± 0.67 |
| n strips | 21 | 19 | 18 | 22 |
| n hearts | 5 | 5 | ||
| . | WT . | cMyBP-C KO . | ||
|---|---|---|---|---|
| AP | MLCK | AP | MLCK | |
| Fmin (kN m−2) | 1.15 ± 0.10 | 1.37 ± 0.13 | 1.46 ± 0.12 | 1.55 ± 0.12 |
| Fabs (kN m−2) | 13.55 ± 0.55a | 17.76 ± 0.85b | 12.21 ± 0.51 | 12.49 ± 0.67 |
| Fdev (kN m−2) | 12.55 ± 0.53a | 16.56 ± 0.85b | 10.99 ± 0.47 | 11.15 ± 0.62 |
| pCa50 | 5.80 ± 0.02a | 5.95 ± 0.03b | 5.86 ± 0.02a | 6.15 ± 0.03 |
| nH | 6.32 ± 0.42 | 6.34 ± 0.68b | 4.50 ± 0.38 | 4.48 ± 0.34 |
| Fmax (kN m−2) | 13.06 ± 0.60a | 16.50 ± 0.81b | 11.14 ± 0.51 | 11.40 ± 0.67 |
| n strips | 21 | 19 | 18 | 22 |
| n hearts | 5 | 5 | ||
Fmin, absolute stress value at pCa 8.0; Fabs, absolute stress value at pCa 4.8; Fdev, Ca2+-activated, developed stress (Tmax − Tmin); pCa50, nH, and Fmax (= maximal stress) represent fit parameters to a three-parameter Hill equation for the Fdev-pCa relationship; n strips, total number of technical replicates (4–7 per heart); n hearts, number of biological replicates.
P < 0.05 effect of MLCK treatment within the same genotype.
P < 0.05 effect of genotype within same treatment type.